Huizi Sha

1.3k total citations
41 papers, 1.1k citations indexed

About

Huizi Sha is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Huizi Sha has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 15 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Huizi Sha's work include Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (14 papers) and RNA Interference and Gene Delivery (7 papers). Huizi Sha is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (14 papers) and RNA Interference and Gene Delivery (7 papers). Huizi Sha collaborates with scholars based in China, India and Canada. Huizi Sha's co-authors include Baorui Liu, Lianru Zhang, Fanyan Meng, Zhengyun Zou, Fangjun Chen, Lixia Yu, Hanqing Qian, Shu Su, Juan Du and Jie Shao and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Huizi Sha

39 papers receiving 1.0k citations

Peers

Huizi Sha
Comparison fields: 5 of 79
  • Molecular Biology 577
  • Oncology 401
  • Biomedical Engineering 309
  • Immunology 277
  • Biomaterials 245
Replace Shabnum Patel with:
Shabnum Patel United States
John‐Michael Williford United States
Andrew Satterlee United States
Yuqing Xie China
Yuebao Zhang United States
Lorena Simón‐Gracia Estonia
Patricia Álamo Spain
James W. Opzoomer United Kingdom
Taek-Chin Cheong United States
Hassan Dianat‐Moghadam Iran
Shabnum Patel United States View profile →
Citations per field, relative to Huizi Sha
Huizi Sha · 1×
Citations per year, relative to Huizi Sha
Huizi Sha · 1×

Countries citing papers authored by Huizi Sha

Since Specialization
Citations

This map shows the geographic impact of Huizi Sha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huizi Sha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huizi Sha more than expected).

Fields of papers citing papers by Huizi Sha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huizi Sha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huizi Sha. The network helps show where Huizi Sha may publish in the future.

Co-authorship network of co-authors of Huizi Sha

This figure shows the co-authorship network connecting the top 25 collaborators of Huizi Sha. A scholar is included among the top collaborators of Huizi Sha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huizi Sha. Huizi Sha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 8
2 1
3 4
4 12
5 1
6 4
7 12
8 9
9 1
10 2
11 94
12 76
13 16
14 21
15 16
16 22
17 42
18 22
19 85
20 33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026